EP3283087A4 - Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions - Google Patents

Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions Download PDF

Info

Publication number
EP3283087A4
EP3283087A4 EP16780681.9A EP16780681A EP3283087A4 EP 3283087 A4 EP3283087 A4 EP 3283087A4 EP 16780681 A EP16780681 A EP 16780681A EP 3283087 A4 EP3283087 A4 EP 3283087A4
Authority
EP
European Patent Office
Prior art keywords
microbiome
therapeutics
derived diagnostics
conditions
endocrine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16780681.9A
Other languages
German (de)
French (fr)
Other versions
EP3283087A1 (en
Inventor
Zachary APTE
Daniel Almonacid
Jessica RICHMAN
Siavosh Rezvan BEHBAHANI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psomagen Inc
Original Assignee
uBiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by uBiome Inc filed Critical uBiome Inc
Publication of EP3283087A1 publication Critical patent/EP3283087A1/en
Publication of EP3283087A4 publication Critical patent/EP3283087A4/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
EP16780681.9A 2015-04-14 2016-04-13 Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions Pending EP3283087A4 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201562147107P 2015-04-14 2015-04-14
US201562147355P 2015-04-14 2015-04-14
US201562147058P 2015-04-14 2015-04-14
US201562147226P 2015-04-14 2015-04-14
US201562147348P 2015-04-14 2015-04-14
US201562147304P 2015-04-14 2015-04-14
US201562147202P 2015-04-14 2015-04-14
PCT/US2016/027378 WO2016168370A1 (en) 2015-04-14 2016-04-13 Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions

Publications (2)

Publication Number Publication Date
EP3283087A1 EP3283087A1 (en) 2018-02-21
EP3283087A4 true EP3283087A4 (en) 2019-03-13

Family

ID=57126198

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16780681.9A Pending EP3283087A4 (en) 2015-04-14 2016-04-13 Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions

Country Status (4)

Country Link
EP (1) EP3283087A4 (en)
CN (1) CN107708714B (en)
AU (2) AU2016250159A1 (en)
WO (1) WO2016168370A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108350503B (en) * 2015-09-09 2022-09-16 普梭梅根公司 Microbiome derived diagnostic and therapeutic methods and systems for thyroid health problem related disorders
US20210074384A1 (en) * 2018-03-16 2021-03-11 Psomagen, Inc. Method and system for characterization of metabolism-associated conditions, including diagnostics and therapies, based on bioinformatics approach
CN114381507B (en) * 2021-11-25 2024-02-13 杭州拓宏生物科技有限公司 Graves disease marker microorganism and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130121968A1 (en) * 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
WO2015013214A2 (en) * 2013-07-21 2015-01-29 Whole Biome, Inc. Methods and systems for microbiome characterization, monitoring and treatment

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011022660A1 (en) * 2009-08-21 2011-02-24 Puretech Ventures, Llc Methods of diagnosing and treating microbiome-associated disease using interaction network parameters
WO2011107481A2 (en) * 2010-03-01 2011-09-09 Institut National De La Recherche Agronomique Method of diagnostic of inflammatory bowel diseases
CA2791464A1 (en) * 2010-03-01 2011-09-09 Institut National De La Recherche Agronomique Method of diagnosis of obesity
EP2773357A4 (en) * 2011-11-04 2015-08-26 Gen Mills Inc Methods and compositions for modulating gastrointestinal bacteria to promote health
CA2899925A1 (en) * 2013-02-04 2014-08-07 Seres Therapeutics, Inc. Compositions and methods for inhibition of pathogenic bacterial growth
US20160129053A1 (en) * 2013-05-24 2016-05-12 President And Fellows Of Harvard College Methods of isolating microorganisms and uses thereof
US20150050245A1 (en) * 2013-08-14 2015-02-19 Tntgamble, Inc. Methods and delivery system for beneficial additive and subtractive biological agents to promote balanced mammalian gastrointestinal flora
US9703929B2 (en) * 2014-10-21 2017-07-11 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics
CN108064132A (en) * 2014-10-31 2018-05-22 霍勒拜欧姆公司 The method and composition related with the antimicrobial treatments of illness and diagnosis
EP3283086A4 (en) * 2015-04-13 2019-04-24 Ubiome Inc. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features
EP3283085A4 (en) * 2015-04-13 2019-04-10 Ubiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features
WO2016168364A1 (en) * 2015-04-13 2016-10-20 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
EP3283649A4 (en) * 2015-04-14 2019-03-20 Ubiome Inc. Method and system for microbiome-derived characterization, diagnostics, and therapeutics for cardiovascular disease conditions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130121968A1 (en) * 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
WO2015013214A2 (en) * 2013-07-21 2015-01-29 Whole Biome, Inc. Methods and systems for microbiome characterization, monitoring and treatment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VIRILI CAMILLA ET AL: "Does microbiota composition affect thyroid homeostasis?", ENDOCRINE, HUMANA PRESS, INC, US, vol. 49, no. 3, 17 December 2014 (2014-12-17), pages 583 - 587, XP035520794, ISSN: 1355-008X, [retrieved on 20141217], DOI: 10.1007/S12020-014-0509-2 *

Also Published As

Publication number Publication date
AU2022200575A1 (en) 2022-02-17
CN107708714A (en) 2018-02-16
CN107708714B (en) 2022-07-22
WO2016168370A1 (en) 2016-10-20
EP3283087A1 (en) 2018-02-21
AU2016250159A1 (en) 2017-11-09

Similar Documents

Publication Publication Date Title
EP3209803A4 (en) Method and system for microbiome-derived diagnostics and therapeutics
EP3347495A4 (en) Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with gastrointestinal health
EP3149698A4 (en) Method and system for image georegistration
EP3164805A4 (en) Method and system for selective document redaction
EP3261054A4 (en) Order pushing method and system
EP3260813A4 (en) Ranging system and ranging method
EP3347367A4 (en) Method and system for microbiome-derived diagnostics and therapeutics for bacterial vaginosis
EP3384203B8 (en) Control system and method for pressure-let-downs stations
EP3308371A4 (en) System and method for digital watermarking
EP3346910A4 (en) Method and system for microbiome-derived diagnostics and therapeutics for eczema
GB2564517B (en) System and method for geofencing
EP3323096A4 (en) System and method for facilitating refunds
EP3283086A4 (en) Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features
EP3346912A4 (en) Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with cerebro-craniofacial health
EP3306908A4 (en) Image acquisition system and image acquisition method
EP3273648A4 (en) System and method
EP3105965A4 (en) System and method for connection rehoming
EP3283085A4 (en) Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features
EP3311524A4 (en) System and method for coverage enhancement
EP3283084A4 (en) Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions
EP3327402A4 (en) Inspection system and inspection method
EP3283648A4 (en) Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues
EP3217967A4 (en) System and method for preventing alopecia
EP3318972A4 (en) System for providing application list and method therefor
EP3283650A4 (en) Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171020

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: G06F 19/18 20110101AFI20181026BHEP

Ipc: G16H 50/20 20180101ALI20181026BHEP

Ipc: G16H 50/70 20180101ALI20181026BHEP

Ipc: G16H 50/50 20180101ALI20181026BHEP

Ipc: C12Q 1/68 20180101ALI20181026BHEP

Ipc: G06F 19/24 20110101ALI20181026BHEP

Ipc: A61K 35/741 20150101ALI20181026BHEP

Ipc: G01N 33/48 20060101ALI20181026BHEP

Ipc: G01N 33/569 20060101ALI20181026BHEP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0035740000

Ipc: C12Q0001680000

A4 Supplementary search report drawn up and despatched

Effective date: 20190207

RIC1 Information provided on ipc code assigned before grant

Ipc: G16H 50/20 20180101ALI20190218BHEP

Ipc: G01N 33/48 20060101ALI20190218BHEP

Ipc: G01N 33/569 20060101ALI20190218BHEP

Ipc: G16H 50/50 20180101ALI20190218BHEP

Ipc: C12Q 1/68 20180101AFI20190218BHEP

Ipc: A61K 35/741 20150101ALI20190218BHEP

Ipc: G16H 50/70 20180101ALI20190218BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190910

19U Interruption of proceedings before grant

Effective date: 20191011

19W Proceedings resumed before grant after interruption of proceedings

Effective date: 20201201

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

D18D Application deemed to be withdrawn (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PSOMAGEN, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20231024